Hyperscale Data Subsidiary Ault Global Commodities Enters into Agreement with The Wyoming Reserve for Secure Precious Metals Storage and Vaulting

Posted 6/1/2026 5:00:00 AM- PR Newswire

CALX Investors Have Opportunity to Lead Calix, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 4:02:00 AM- PR Newswire

AVAV Investors Have Opportunity to Lead AeroVironment, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 4:02:00 AM- PR Newswire

ZIM Board of Directors Appoints Dr. Chen Lichtenstein as President and CEO of the Company; will also be joining its Board of Directors

Posted 6/1/2026 4:00:00 AM- PR Newswire

PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:59:00 AM- PR Newswire

Ravi Chandran Krishnadas joins RWS as Senior Vice President & Country Lead, India

Posted 6/1/2026 4:00:00 AM- PR Newswire

GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:59:00 AM- PR Newswire

SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:58:00 AM- PR Newswire

IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:58:00 AM- PR Newswire

POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:57:00 AM- PR Newswire

CVLT Investors Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:56:00 AM- PR Newswire

FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:55:00 AM- PR Newswire

GPK Investors Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:55:00 AM- PR Newswire

SES AI Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SES

Posted 6/1/2026 3:54:00 AM- PR Newswire

SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:53:00 AM- PR Newswire

Meitav Investment House Announces Immediate Report Concerning Selected Business Data for April 2026

Posted 6/1/2026 3:53:00 AM- PR Newswire

Globant S.A. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GLOB

Posted 6/1/2026 3:53:00 AM- PR Newswire

UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:52:00 AM- PR Newswire

Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP

Posted 6/1/2026 3:51:00 AM- PR Newswire

Upstart Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UPST

Posted 6/1/2026 3:52:00 AM- PR Newswire

Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS

Posted 6/1/2026 3:50:00 AM- PR Newswire

Stellantis N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - STLA

Posted 6/1/2026 3:50:00 AM- PR Newswire

STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:48:00 AM- PR Newswire

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:45:00 AM- PR Newswire

Share buybacks in Ericsson during the period May 25 - May 29, 2026

Posted 6/1/2026 3:10:00 AM- PR Newswire

China's Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA

Posted 6/1/2026 3:04:00 AM- PR Newswire

VERI Investors Have Opportunity to Lead Veritone, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:02:00 AM- PR Newswire

Silvio Napoli Assumes Role as CEO of Lucid Following Completion of Leadership Transition

Posted 6/1/2026 3:01:00 AM- PR Newswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Posted 6/1/2026 3:00:00 AM- PR Newswire

Sapiens welcomes ADIA as an investor

Posted 6/1/2026 3:00:00 AM- PR Newswire

OCI Global Announces Sale of 50% of OCI Nitrogen to AGROFERT

Posted 6/1/2026 2:39:00 AM- PR Newswire

Skanska builds Second Avenue Subway Project Phase II in New York, USA, for USD 498M, about SEK 4.6 billion

Posted 6/1/2026 2:04:00 AM- PR Newswire

Dott provides an update on timing of 2025 Annual Report

Posted 6/1/2026 2:00:00 AM- PR Newswire

VINFAST AND AUTOBRAINS LAUNCH FIRST AGENTIC AI L4 PROGRAM FOR SOUTHEAST ASIA WITH NVIDIA

Posted 6/1/2026 1:57:00 AM- PR Newswire

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

Posted 6/1/2026 1:51:00 AM- PR Newswire

Sinch appoints Sophie Cheng as Chief Marketing Officer

Posted 6/1/2026 1:42:00 AM- PR Newswire

Supermicro Introduces DCBBS Blueprints for NVIDIA Vera Rubin NVL72 and NVIDIA HGX™ Rubin NVL8, Built to Scale from 5MW to 1GW as an End-to-End Total Solution

Posted 6/1/2026 1:35:00 AM- PR Newswire

MediaTek Collaborates with NVIDIA on the RTX Spark to Power the Next Wave of Windows PC Experiences

Posted 6/1/2026 1:30:00 AM- PR Newswire

Blaize and Winmate Bring Rugged Edge AI from the U.S. to the Global Stage at COMPUTEX 2026, Advancing Joint Mission-Critical and Industrial Solutions

Posted 6/1/2026 1:00:00 AM- PR Newswire

XPENG Announces Vehicle Delivery Results for May 2026

Posted 6/1/2026 12:47:00 AM- PR Newswire

Landis+Gyr Capital Markets Day 2026

Posted 6/1/2026 12:45:00 AM- PR Newswire

HONEYWELL UNVEILS NEW BRANDS EFFECTIVE POST SPIN-OFF: HONEYWELL TECHNOLOGIES AND HONEYWELL AEROSPACE

Posted 6/1/2026 12:05:00 AM- PR Newswire

Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader

Posted 6/1/2026 12:01:00 AM- PR Newswire

IREN and BE Networks Accelerate Deployment of Large-Scale AI Factory with NVIDIA DSX Air

Posted 6/1/2026 12:01:00 AM- PR Newswire

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Posted 5/31/2026 11:09:00 PM- PR Newswire

Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou

Posted 5/31/2026 11:09:00 PM- PR Newswire

Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers

Posted 5/31/2026 11:00:00 PM- PR Newswire

TrendAI™ Launches Inception Program to Power the Next Wave of Secure AI Innovation

Posted 5/31/2026 11:00:00 PM- PR Newswire

IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications

Posted 5/31/2026 10:12:00 PM- PR Newswire

LG Display to showcase world's largest Gaming OLED lineup in Taiwan

Posted 5/31/2026 9:30:00 PM- PR Newswire

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept

Posted 5/31/2026 8:15:00 PM- PR Newswire

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

Posted 5/31/2026 8:15:00 PM- PR Newswire

2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

Posted 5/31/2026 8:00:00 PM- PR Newswire

2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC

Posted 5/31/2026 8:00:00 PM- PR Newswire

MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026

Posted 5/31/2026 8:00:00 PM- PR Newswire

TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026

Posted 5/31/2026 7:30:00 PM- PR Newswire

Cango Inc. Reports First Quarter 2026 Unaudited Financial Results

Posted 5/31/2026 6:00:00 PM- PR Newswire

Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion

Posted 5/31/2026 4:30:00 PM- PR Newswire

iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo

Posted 5/31/2026 12:03:00 PM- PR Newswire

CPKC to maintain rail operations across Canada during IBEW strike

Posted 5/31/2026 10:18:00 AM- PR Newswire

HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

Posted 5/31/2026 9:00:00 AM- PR Newswire

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited

Posted 5/31/2026 8:29:00 AM- PR Newswire

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

Posted 5/31/2026 8:27:00 AM- PR Newswire

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer

Posted 5/31/2026 8:01:00 AM- PR Newswire

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

Posted 5/31/2026 8:00:00 AM- PR Newswire

SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER

Posted 5/30/2026 10:15:00 PM- PR Newswire

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Posted 5/30/2026 8:09:00 PM- PR Newswire

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

Posted 5/30/2026 8:00:00 PM- PR Newswire

PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit

Posted 5/30/2026 7:55:00 PM- PR Newswire

STLA Deadline: STLA Investors with Losses in Excess of $100K Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

Posted 5/30/2026 6:36:00 PM- PR Newswire

SES AI Corporation Deadline: SES Investors with Losses in Excess of $100K Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

Posted 5/30/2026 5:31:00 PM- PR Newswire

NUAI Deadline: NUAI Investors with Losses in Excess of $100K Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit

Posted 5/30/2026 5:07:00 PM- PR Newswire

Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

Posted 5/30/2026 2:30:00 PM- PR Newswire

/C O R R E C T I O N -- Hyundai Motor America/

Posted 5/30/2026 11:35:00 AM- PR Newswire

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

Posted 5/30/2026 9:57:00 AM- PR Newswire

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

Posted 5/30/2026 8:00:00 AM- PR Newswire

The Rosen Law Firm, P.A. Continues to Remind Investors of the Proposed Class Action Settlement on Behalf of Purchasers of Sun Communities, Inc. Publicly-Traded Common Stock - SUI

Posted 5/30/2026 8:00:00 AM- PR Newswire

Number of shares and votes in BioArctic AB (publ) as of May 29, 2026

Posted 5/30/2026 4:31:00 AM- PR Newswire

Replenish Nutrients: Market Has Yet to Price in the H2 2026 Capacity and Licensing Inflection

Posted 5/30/2026 4:14:00 AM- PR Newswire

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

Posted 5/29/2026 11:32:00 PM- PR Newswire

Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

Posted 5/29/2026 11:29:00 PM- PR Newswire

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

Posted 5/29/2026 10:00:00 PM- PR Newswire

SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES

Posted 5/29/2026 10:00:00 PM- PR Newswire

Sportradar Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Sportradar Group AG - SRAD

Posted 5/29/2026 10:00:00 PM- PR Newswire

CLPS Incorporation Receives Nasdaq Notification Regarding Minimum Bid Price Requirements

Posted 5/29/2026 8:16:00 PM- PR Newswire

IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit

Posted 5/29/2026 7:13:00 PM- PR Newswire

NEUBERGER REAL ESTATE SECURITIES INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 6:18:00 PM- PR Newswire

Gap Inc. Investigation Initiated: SueWallSt Investigates the Officers and Directors of Gap Inc. (GAP)

Posted 5/29/2026 6:14:00 PM- PR Newswire

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 5:48:00 PM- PR Newswire

Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs

Posted 5/29/2026 5:31:00 PM- PR Newswire

Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice

Posted 5/29/2026 5:30:00 PM- PR Newswire

Hydro One seeks approval from the Ontario Energy Board to build the Orléans Area Reinforcement Project

Posted 5/29/2026 5:19:00 PM- PR Newswire

NEUBERGER NEXT GENERATION CONNECTIVITY FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 5:06:00 PM- PR Newswire

NEUBERGER REAL ESTATE SECURITIES INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 5:07:00 PM- PR Newswire

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 5:05:00 PM- PR Newswire

JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

Posted 5/29/2026 5:03:00 PM- PR Newswire

JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

Posted 5/29/2026 5:02:00 PM- PR Newswire

PBF Energy to Participate in Bank of America Energy and Power Credit Conference

Posted 5/29/2026 5:00:00 PM- PR Newswire

NEUBERGER ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

Posted 5/29/2026 5:00:00 PM- PR Newswire

POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Posted 5/29/2026 4:42:00 PM- PR Newswire